ZDA
SGTX

Zweig-DiMenna Associates’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Zweig-DiMenna Associates’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,116
Closed -$1.27M – 203
2021
Q2 		$1.27M Buy
9,116
+1,178
+15% +$164K 0.08% 155
2021
Q1 		$2.31M Buy
7,938
+7,461
+1,564% +$2.17M 0.16% 115
2020
Q4 		$298K Buy
+477
New +$298K 0.02% 131